Latest News

Vulcabras S.A. ( BVMF:VULC3 ) came out with its quarterly results last week, and we wanted to see how the business is...

Cooling US inflation expectations and wage growth have shifted attention back to companies that can grow earnings even if interest rate paths stay uncertain. That is where the Healthy high growth potential screener earns a closer look. It focuses on stocks where analysts see strong earnings growth and balance sheets that pass basic health checks. This article highlights 3 standouts that fit that profile today. The 3 stocks below are just a starting sample. The full screen surfaced another 272...

Telefonaktiebolaget LM Ericsson (OM:ERIC B) is back in focus after AT&T selected the company to supply 600 MHz dual-band radios for its newly acquired spectrum, alongside a private LTE deployment win with Tampa Electric Company. See our latest analysis for Telefonaktiebolaget LM Ericsson. Despite the recent contract wins, Ericsson’s 1 month share price return is down 8.17%, and the 3 month share price return is down 11.77%. However, the 1 year total shareholder return of 37.67% and 3 year...

BorgWarner (NYSE:BWA) announced multiple new contracts for variable cam timing systems in Europe and China, including a conquest award from a China based automaker. The company reported that these variable cam timing wins expand its position with existing customers and replace a competitor on a China program. BorgWarner also secured new awards for high voltage inverters and integrated drive modules for hybrid and electric vehicle platforms. The company described these contracts as material...

On 5 August 2026, Takeda Pharmaceutical announced that the U.S. FDA approved ORZEYFUL (oveporexton), a first-in-class oral orexin receptor 2 agonist, for treating narcolepsy type 1 with cataplexy in adults, with commercial launch pending DEA controlled substance scheduling. This approval gives Takeda a differentiated entry into a rare disease market of an estimated 120,000 U.S. patients, addressing the underlying orexin deficiency rather than only individual narcolepsy symptoms. We will now...

FTAI Aviation (FTAI) shares have been reacting to the company’s July 29 earnings release and dividend declarations, which gave investors fresh data on revenue, profit and cash returns in the latest quarter. See our latest analysis for FTAI Aviation. The latest earnings and dividend announcements have been the main catalysts for FTAI Aviation’s recent trading, with the stock easing 2.3% on a 1-day share price return while still showing a 4.97% 7-day share price gain and a very large 5-year...

Why ORIC Pharmaceuticals Stock Is Back in Focus After Q2 Earnings ORIC Pharmaceuticals (ORIC) has drawn fresh attention after reporting second quarter and first half 2026 results, with a wider net loss but an improved basic loss per share from continuing operations. See our latest analysis for ORIC Pharmaceuticals. The earnings update and recent shelf registration have come alongside strong share price momentum. ORIC Pharmaceuticals has posted a 7 day share price return of 21.95% and a 90 day...

Dutch Bros Inc. reported past second-quarter 2026 results with revenue of US$550.85 million and net income of US$37.41 million, alongside higher full-year revenue guidance of US$2.10–US$2.13 billion. The company also agreed to acquire up to 65 former Salad and Go drive-thru sites for US$105 million, aiming to convert them into Dutch Bros locations and accelerate its footprint expansion across Arizona, Nevada, Oklahoma, and Texas in 2027. We’ll now examine how Dutch Bros’ raised revenue...

Central banks in several major economies have kept interest rates steady while inflation in many places still comes from services and everyday costs. That mix keeps income focused investors searching for yield that looks more reliable than cash or short term bonds. Well covered, growing and stable dividends above 5% can stand out. This article walks through three Dividend Powerhouses from the screener that fit that brief. The three stocks highlighted below are just a small sample, as the full...

Western Union stock has delivered a sharp 52.8% decline over the past 5 years, yet its current valuation checks still suggest the shares lean cheap relative to fundamentals. This makes the recent price level a key focus for investors trying to judge whether that pessimism has already been fully reflected. The 52.8% share price decline over 5 years points to a market that has marked Western Union down heavily and raises the question of whether expectations have been reset too...

Cellebrite DI recently expanded its exclusive partnership with SkySafe to strengthen drone detection and airspace intelligence tools used in digital investigations, and the company is set to release its second-quarter 2026 results on August 13, 2026. This combination of product expansion into drone-related forensics and an imminent earnings update highlights how Cellebrite is positioning its platform for emerging investigative needs. We'll now examine how the expanded SkySafe partnership...

In August 2026, ThredUp Inc. reported second-quarter 2026 results showing sales of US$90.77 million versus US$77.66 million a year earlier, alongside a wider net loss of US$5.94 million and basic loss per share of US$0.05. The company also issued new revenue guidance for the third and fourth quarters and full year 2026, outlining expected mid‑single‑digit to low‑double‑digit year-over-year growth, which gives investors clearer visibility into its near-term scale ambitions despite ongoing...

CACI International Inc has reported past fourth-quarter 2026 results showing sales rising to US$2,709.06 million while net income held roughly steady at about US$156.75 million, and full-year sales increasing to US$9,567.78 million with net income of US$535.81 million, alongside issuing fiscal 2027 guidance for higher revenue, earnings and diluted EPS. Recent multi-year federal contract wins in drone defense and HR modernization, including participation in a nearly US$400.00 million...

In August 2026, ams-OSRAM reported second-quarter results showing sales of €805 million alongside a net loss of €122 million, and issued guidance for third-quarter revenues between €770 million and €870 million while signalling slightly lower full-year 2026 revenue due to divestments and foreign exchange effects. An important implication is that modest year-on-year revenue softening is driven not only by operating conditions but also by portfolio reshaping and currency headwinds, which...

Gold Royalty Corp. recently reported its second-quarter and first-half 2026 results, with gold equivalent ounce production rising to 1,757 for the quarter and 3,677 for the half-year, alongside sales of US$6.73 million and net income of US$1.78 million in the quarter and US$3.55 million for the first six months. The company also reaffirmed its 2026 production guidance of 7,500 to 9,300 gold equivalent ounces, based on assumed gold and copper prices, underlining how its expanding royalty...

RadNet stock has delivered a strong 136.9% return over the past 5 years, yet today investors face mixed valuation signals as an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach screens the shares as undervalued while market multiples point to a richer price. Over 5 years RadNet has returned 136.9%, which puts extra focus on whether the current share price still leaves room for an attractive risk adjusted payoff. The recent FDA clearance for DeepHealth Breast Ultrasound...

RXO stock jumped about 7% to US$21.70 after the Q2 print, a sharp move for a freight brokerage that has frustrated investors over the past month with a roughly 19% slide. The reaction hinges on one thing: the margin story finally showed some relief, even as the company remained loss making. Adjusted earnings before interest, tax, depreciation and amortization came in at US$40 million and net income loss narrowed to US$9 million on US$1.8b of revenue. For a capital tight, cash hungry model,...

Amgen recently received a positive opinion from the European Medicines Agency’s CHMP to expand Repatha’s use to adults with or at high risk for atherosclerotic cardiovascular disease in Europe, following Phase 3 VESALIUS-CV data showing meaningful reductions in first major cardiovascular events and LDL-C levels. This expanded cardiovascular prevention use, if approved by the European Commission, could broaden Repatha’s eligible patient pool and reinforce Amgen’s position in treating...

In recent days, analysts’ forecasts for Amcor’s upcoming quarterly results have pointed to earnings of $1.20 per share, with revenues and both flexible and rigid packaging segments expected to grow meaningfully year over year. This upbeat view of broad-based segment growth suggests analysts see operational momentum across Amcor’s core packaging businesses rather than a narrow, one-off improvement. We’ll now examine how these stronger-than-expected earnings projections, particularly for rigid...

Board meeting puts potential Nakanishi stock split in focus Nakanishi (TSE:7716) has called a board meeting for 7 August 2026 to consider a two for one stock split of its common shares, drawing fresh attention to the stock’s recent performance and liquidity profile. See our latest analysis for Nakanishi. Nakanishi’s share price has been strong in the lead up to the board meeting, with a 1 month share price return of 8.17%, a 90 day gain of 17.62%, and a year to date rise of 62.66%. Over...

With central banks keeping a close eye on energy markets and inflation, investors are paying more attention to balance sheets than bold promises. That is where Financially Fit Penny Stocks come in. This screener highlights lower priced stocks that still prioritise financial health, which can matter when policy is uncertain. This article walks through 3 of the most interesting picks and why they may be worth a closer look now. The stocks covered below are only a small sample from this...

Duolingo (DUOL) is back in focus after its latest quarterly report and guidance. The company shared second quarter 2026 results together with revenue expectations for the third quarter and full year. See our latest analysis for Duolingo. Duolingo's latest earnings and guidance have come after a sharp move in the stock, with a 1 day share price return of 6.79% but a year to date share price decline of 25.83% and a 1 year total shareholder return that is down 64.65%. That mix of short term...

UFP Industries (UFPI) is back in focus after reporting second quarter 2026 results that showed higher sales but lower net income compared with a year earlier, along with fresh detail on its recent share repurchases. See our latest analysis for UFP Industries. The second quarter earnings release and confirmation of ongoing buybacks have coincided with a 13.29% 1 month share price return and an 11.45% 3 month share price return. However, the 1 year total shareholder return is down 2.43% and the...

Why RB Global Is Back On Investors' Radar After Q2 2026 RB Global (RBA) reported Q2 2026 results and a fresh update on its capital return plans, combining higher revenue and net income with a completed share buyback and a declared dividend. This mix of earnings information and cash returns to shareholders is drawing renewed attention to RB Global stock in early August 2026, especially as investors compare its profile with other business services companies. See our latest analysis for RB...